Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jun 1;47(3):317-319.
doi: 10.1097/FTD.0000000000001299. Epub 2024 Dec 17.

Lamotrigine Use in Lactating Women: Passage Into Breast Milk and Infant Exposure

Affiliations
Case Reports

Lamotrigine Use in Lactating Women: Passage Into Breast Milk and Infant Exposure

Daphne den Besten-Bertholee et al. Ther Drug Monit. .

Abstract

Background: Lamotrigine, an antiseizure medication used for epilepsy and bipolar disorders, is often prescribed to women of childbearing age due to relatively low teratogenic risk. It is known that lamotrigine use in lactation leads to detectable concentrations in breast milk, although concentrations vary significantly among individuals.

Case presentation: A 35-year-old pregnant woman with epilepsy presented to our outpatient clinic. She was seizure-free and was taking lamotrigine 200 mg once daily. She is highly motivated to breastfeed her baby after birth but is concerned about the infant's exposure to lamotrigine through lactation. Lamotrigine concentrations were measured in both the breast milk and plasma of the suckling infants.

Conclusions: Although lamotrigine is excreted into breast milk, and detectable in infants, the benefits of breastfeeding should not be overlooked. Higher plasma concentrations generally lead to higher breast milk concentrations, so aiming for the lowest possible maternal plasma levels is beneficial. These findings underscore the importance of TDM in this population.

Keywords: breastfeeding; infant exposure; lamotrigine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Husein N, Thijs RD, Bunschoten JW, et al. Concerns about lamotrigine. Lancet Neurol. 2021;20:418–419.
    1. Tomson T, Battino D, Bonizzoni E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17:530–538.
    1. Madadi P, Ito S. Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and child. Can Fam Physician. 2010;56:1132–1134.
    1. World Health Organization. World Health Organization; United Nations Children's Fund. Global Strategy for Infant and Young Child Feeding. Available at: https://www.who.int/news-room/fact-sheets/detail/infant-and-young-child-... . Accessed February 5, 2024.
    1. Begg EJ. Studying drugs in human milk: time to unify the approach. J Hum Lactation. 2002;18:323–332.

Publication types

LinkOut - more resources